Sid Sadler
@Sid423
Followers
366
Following
24K
Media
696
Statuses
6K
Diagnosed ccRCC 🩺 • Youngest guy in the urology office by 30 years 😅 • Walk Your Garden 🪴 • I like to photograph things 📸
Nashville, TN
Joined January 2009
Last night I was joined by my wife, new baby, and many others to check out the Tennessee State Capital lit up in orange to #OrangeUp for #KidneyCancerAwarenessMonth. Special thanks to @katy_beckermann @paulosiqamaral and @frank_m_mason for joining me. These are some of the few
4
2
16
RT @KidneyCancer: Registration is OPEN!. Join us for our FREE 2025 Virtual Patient Symposium on Sept 6, hosted by the KCA. Hear from world-….
0
1
0
RT @KidneyCancer: 💡 Did you know some kidney tumors can spontaneously shrink even without treatment?!. We're back with Dr. Eric Kauffman @R….
kidneycancer.org
Dr. Eric Kauffman received a Kidney Cancer Association Research Award in 2021 for a project called “Biology of spontaneously regressing renal cell
0
2
0
Couldn’t agree more with @kaydaustin here. If you’re a patient, doctor, etc please give this episode a listen! This dynamic and topic is so important and isn’t talked about enough.
0
2
5
RT @NashSevereWx: Looking ahead, NWS is seeing indications that this heat wave will likely be a long-duration event. The high pressure ridg….
0
19
0
RT @GUconference: The future is now. Don’t miss “Tools for Tomorrow’s Oncologist” at #WorldGU25—an essential session featuring Drs. @katy_b….
0
5
0
RT @kidneycan: We're honored to present the KidneyCAN Hall of Fame Award to Dr. Marston Linehan of the National Cancer Institute. Dr. Line….
0
1
0
RT @katy_beckermann: 💡 Great review of progress over the last 10 years in 1st-line metastatic RCC 🚀 and a call from David McDermott to work….
0
9
0
RT @kidneycan: At #KCRS25, we asked: Who here has received Department of Defense CDMRP funding or participated in a program supported by it….
0
4
0
RT @CancerNetwrk: 🎙️Live at #KCRS2025, we just spoke with David Braun, MD, PhD, about his presentation on personalized vaccines in kidney c….
0
3
0
RT @NazliDizman: 📢KCRS25 kicks off! .👏Truly inspired by the focus on non-clear cell renal cell carcinoma at #KCRS25. An area with importan….
0
11
0
RT @KidneyCancer: 🤗 We're excited to have our friend @KimrynRathmell @OSUCCC_James join us for a conversation about leadership and career….
0
6
0
Check this out folks 👀. Please join the Kidney Cancer Association for their annual Virtual Patient Symposium on Saturday, September 6th!. This FREE symposium brings leading kidney cancer experts directly to patients, caregivers, family members, and anyone looking to learn more
0
0
1
Check this out folks 👀. Please join the Kidney Cancer Association for their annual Virtual Patient Symposium on Saturday, September 6th!. This FREE symposium brings leading kidney cancer experts directly to patients, caregivers, family members, and anyone looking to learn more
0
0
0
Thrilled and honored to be asked to to be on the @KidneyCancer Patient and Caregiver Advisory Council. Change starts from the bottom. We have to continue on the advances from our amazing researchers and doctors. Patients are HUNGRY for knowledge when there is so much.
Say hello to the newest members of our Patient & Caregiver Advisory Council (PCAC)! 🧡 Our PCAC plays a vital role in amplifying the patient voice and connecting the KCA to the broader #kidneycancer community. We're are so thrilled to grow this wonderful council.
1
0
7
RT @NazliDizman: 🤩Preclinical and clinical data on #Ivonescimab in other cancers shows an immense promise for our patients with #KidneyCanc….
0
7
0
RT @BraunMDPhD: 1/ Recently, our lab has worked with outstanding groups (#TeamScience) to address some key questions in kidney cancer immun….
0
16
0
RT @YaleCancer: A rare #kidneycancer, chromophobe RCC, resists traditional immunotherapy because of its ability to hide from the immune sys….
yalecancercenter.org
Cancer fighting T cells, the immune system’s primary enforcers, are scarce in the rare kidney cancer called chromophobe renal cell carcinoma and those that are
0
5
0
RT @PavlosMsaouel: 🚀 Now enrolling @MDAndersonNews: IVORY trial of #ivonescimab (first-in-class PD1×VEGF bispecific) in metastatic clear ce….
0
26
0